Immunotoxicology assessment plays a large role in the drug development pipeline, especially for large molecules and biologics. Researchers in early drug development have a wide variety of immunologic assay methods available that can support research endpoints and offer opportunities for much clearer views into the efficacy and safety of a compound.

In July 2021, an evaluation of Organisation for Economic Cooperation and Development (OECD) 443 studies led by the European Chemicals Agency (ECHA) revealed critical issues with study designs that had the potential to compromise data analysis and interpretation.

Test Data Simulator (TDS) tool helps overcome source data inconsistencies and prepare with your standards program even before the first patient visit.

In this webinar, speakers discuss the incorporation of DCT methodologies into oncology clinical trials along with special considerations for pediatric and elderly participants.

This video highlights the importance of Mobile Clinical Services (MCS) and how they can help to overcome patient challenges.

From study design to feasibility assessment to patient enrollment, many important considerations factor into achieving timely completion of renal/hepatic impairment studies.

Labcorp Bioanalytical Services webinar entitled, "Oiling the oligo engine and running without additives -- the continuing journey" presents a summary of recent progress of the quantitative bioanalytical LC-MS of oligonucleotides without ion-pairing, dwelling both on chromatographic and extractive aspects.

Join our educational webinar as we explore the benefits of DCT solutions in dermatology research to reduce the on-site burden for both investigators and patients.

Labcorp's Patient Access Solutions focuses on the expertise and empathy to deliver success.